The US Treasury recently announced that it will need to borrow far more than expected, now over $1T for Q3 2025. Read the ...

Rocket Lab (RKLB) acquires Geost to enhance U.S. defense projects with advanced EO/IR technologies, bolstering capabilities ...

Archer Aviation's Q2 report showcases progress toward revenue, a $1.7B cash runway, and growth potential. Check out why I ...

Strategic focus continues to be on Anaphylm’s FDA approval, commercial launch, and financing. Management reiterated international expansion plans for Anaphylm, whereas the previous quarter emphasized ...

Discover key insights from Hydrofarm's Q2 2025 earnings call: restructuring for $3M+ savings, stronger margins, and focus on proprietary, noncannabis growth.

President Donald Trump, who has long vented against Federal Reserve Chair Jerome Powell for not cutting rates, has found a ...

Discover Acurx Pharmaceuticals' Q2 2025 highlights: key patent milestones, Phase IIb trial success, cost controls, and funding strategies for Phase III.

The suspension comes as the U.S. Department of Commerce recently granted Nvidia and AMD ( AMD) permission to resume sales of ...

Retail inflation held few surprises in July, with the overall number steady but core inflation, which the Fed watches, ...

Sanofi (SNY) halts shipments of cholesterol drug Praluent developed with Regeneron (REGN) due to availability issues. Read ...

Discover why TWLO's pullback offers a buying opportunity. Explore its valuation, promising launches, improved metrics, and ...

VST's bright prospects have been well embedded in its increasingly premium valuations and the triple digits rally since the ...